相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Caffeine derived platinum(II) N-heterocyclic carbene complexes with multiple anti-cancer activities
Jing-Jing Zhang et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2015)
A novel aminotriazole-based NHC complex for the design of gold(I) anti-cancer agents: synthesis and biological evaluation
T. V. Serebryanskaya et al.
MEDCHEMCOMM (2015)
Crystal structure refinement with SHELXL
George M. Sheldrick
ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY (2015)
Recent developments of metal N-heterocyclic carbenes as anticancer agents
Sainath Babaji Aher et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Caffeine-Based Gold(I) N-Heterocyclic Carbenes as Possible Anticancer Agents: Synthesis and Biological Properties
Benoit Bertrand et al.
INORGANIC CHEMISTRY (2014)
Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs
Wukun Liu et al.
CHEMICAL SOCIETY REVIEWS (2013)
Redox-Switchable Ring-Closing Metathesis: Catalyst Design, Synthesis, and Study
Kuppuswamy Arumugam et al.
CHEMISTRY-A EUROPEAN JOURNAL (2013)
Modulation of oxidative stress as an anticancer strategy
Chiara Gorrini et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Cationic Iridium Complexes Containing Anionic Iridium Counterions Supported by Redox-Active N-Heterocyclic Carbenes
Kuppuswamy Arumugam et al.
ORGANOMETALLICS (2013)
Targeting cellular metabolism to improve cancer therapeutics
Y. Zhao et al.
CELL DEATH & DISEASE (2013)
Singlet Carbenes Derived from Ferrocene and Closely Related Sandwich Complexes
Ulrich Siemeling
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2012)
Structure-Activity Relationship and Mode of Action of N-(6-Ferrocenyl-2-naphthoyl) Dipeptide Ethyl Esters: Novel Organometallic Anticancer Compounds
Aine Mooney et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Gold(I) Carbene Complexes Causing Thioredoxin 1 and Thioredoxin 2 Oxidation as Potential Anticancer Agents
Esther Schuh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Gold(I) Complexes Bearing Sterically Imposing, Saturated Six- and Seven-Membered Expanded Ring N-Heterocyclic Carbene Ligands
Jay J. Dunsford et al.
ORGANOMETALLICS (2012)
A texaphyrin-oxaliplatin conjugate that overcomes both pharmacologic and molecular mechanisms of cisplatin resistance in cancer cells
Jonathan F. Arambula et al.
MEDCHEMCOMM (2012)
Overcoming biochemical pharmacologic mechanisms of platinum resistance with a texaphyrin-platinum conjugate
Jonathan F. Arambula et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Therapeutic applications of gold complexes: lipophilic gold(III) cations and gold(I) complexes for anti-cancer treatment
Chi-Ming Che et al.
CHEMICAL COMMUNICATIONS (2011)
Gold(III) N-Heterocyclic Carbene Complexes Mediated Synthesis of β-Enaminones From 1,3-Dicarbonyl Compounds and Aliphatic Amines
Manoja K. Samantaray et al.
INORGANIC CHEMISTRY (2011)
Organometallic Anticancer Compounds
Gilles Gasser et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Synthesis and anticancer properties of gold(I) and silver(I) N-heterocyclic carbene complexes
Tammy J. Siciliano et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2011)
New and Easily Accessible Nitrogen Acyclic Gold(I) Carbenes: Structure and Application in the Gold-Catalyzed Phenol Synthesis as well as the Hydration of Alkynes
A. Stephen K. Hashmi et al.
ADVANCED SYNTHESIS & CATALYSIS (2010)
Anticancer Therapeutics That Target Selenoenzymes: Synthesis, Characterization, in vitro Cytotoxicity, and Thioredoxin Reductase Inhibition of a Series of Gold(I) Complexes Containing Hydrophilic Phosphine Ligands
Elena Vergara et al.
CHEMMEDCHEM (2010)
Benzimidazol-2-ylidene Gold(I) Complexes Are Thioredoxin Reductase Inhibitors with Multiple Antitumor Properties
Riccardo Rubbiani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Palladium Complexes of Planar Chiral Ferrocenyl Phosphine-NHC Ligands: New Catalysts for the Asymmetric Suzuki-Miyaura Reaction
Nathalie Debono et al.
ORGANOMETALLICS (2010)
Comparative toxicity of [3]ferrocenophane and ferrocene moieties on breast cancer cells
Meral Gormen et al.
TETRAHEDRON LETTERS (2010)
N-heterocyclic carbenes which readily add ammonia, carbon monoxide and other small molecules
Ulrich Siemeling et al.
CHEMICAL SCIENCE (2010)
Facile synthesis and strong antiproliferative activity of disubstituted diphenylmethylidenyl-[3]ferrocenophanes on breast and prostate cancer cell lines
Meral Gormen et al.
MEDCHEMCOMM (2010)
Ferrocenyl Quinone Methides as Strong Antiproliferative Agents: Formation by Metabolic and Chemical Oxidation of Ferrocenyl Phenols
Didier Hamels et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
A stable crystalline N-heterocyclic carbene with a 1,1 '-ferrocenediyl backbone
Ulrich Siemeling et al.
CHEMICAL COMMUNICATIONS (2009)
Coinage Metal-N-Heterocyclic Carbene Complexes
Joseph C. Y. Lin et al.
CHEMICAL REVIEWS (2009)
On the medicinal chemistry of gold complexes as anticancer drugs
Ingo Ott
COORDINATION CHEMISTRY REVIEWS (2009)
1,1 '-Bis(N-benzimidazolylidene)ferrocene: synthesis and study of a novel ditopic ligand and its transition metal complexes
C. Daniel Varnado et al.
DALTON TRANSACTIONS (2009)
Metal-NHC complexes: a survey of anti-cancer properties
Marie-Laure Teyssot et al.
DALTON TRANSACTIONS (2009)
Six-Membered N-Heterocyclic Carbenes with a 1,1′-Ferrocenediyl Backbone: Bulky Ligands with Strong Electron-Donor Capacity and Unusual Non-Innocent Character
Ulrich Siemeling et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2009)
A Gold(I) Phosphine Complex Containing a Naphthalimide Ligand Functions as a TrxR Inhibiting Antiproliferative Agent and Angiogenesis Inhibitor
Ingo Ott et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
A [3]Ferrocenophane Polyphenol Showing a Remarkable Antiproliferative Activity on Breast and Prostate Cancer Cell Lines
Damian Plazuk et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Maximilian Diehn et al.
NATURE (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Redox-Active N-Heterocyclic Carbenes: Design, Synthesis, and Evaluation of Their Electronic Properties
Evelyn L. Rosen et al.
ORGANOMETALLICS (2009)
Synthesis of a new bidentate NHC-Ag(I) complex and its unanticipated reaction with the Hoveyda-Grubbs first generation catalyst
Giovanni Occhipinti et al.
TETRAHEDRON (2009)
Diaminocarbene[3]ferrocenophanes and their transition-metal complexes
Dimitri M. Khramov et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
Synthesis and anticancer properties of water-soluble zinc ionophores
Darren Magda et al.
CANCER RESEARCH (2008)
A Sugar-Modified Phosphole Gold Complex with Antiproliferative Properties Acting as a Thioredoxin Reductase Inhibitor in MCF-7 Cells
Elodie Viry et al.
CHEMMEDCHEM (2008)
Gold(I) complexes determine apoptosis with limited oxidative stress in Jurkat T cells
Maria Pia Rigobello et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Mitochondria-targeted chemotherapeutics:: The rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols
James L. Hickey et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
A cytotoxic bis(carbene) gold(I) complex of ferrocenyl complexes: synthesis and structural characterisation
Ulrike E. I. Horvath et al.
NEW JOURNAL OF CHEMISTRY (2008)
Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling
Jose C. Juarez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A short history of SHELX
George M. Sheldrick
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES (2008)
Allylic alkylation and amination using mixed (NHC)(phosphine) palladium complexes under biphasic conditions
Alexandre Flahaut et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2007)
A gold(I) phosphine complex selectively induces apoptosis in breast cancer cells: Implications for anticancer therapeutics targeted to mitochondria
Oliver Rackham et al.
BIOCHEMICAL PHARMACOLOGY (2007)
On the medicinal chemistry of ferrocene
Mohammad F. R. Fouda et al.
APPLIED ORGANOMETALLIC CHEMISTRY (2007)
An NQO1-and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by β-lapachone
Erik A. Bey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells
Christine Marzano et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
New (1-phosphanylferrocen-1′- and -2-yl)methyl-linked diaminocarbene ligands:: Synthesis and rhodium(I) complexes
Agnes Labande et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2007)
Tuning the electronic properties of N-heterocyclic carbenes
Steffen Leuthaeusser et al.
CHEMISTRY-A EUROPEAN JOURNAL (2007)
Motexafin gadolinium: A novel redox active drug for cancer therapy
Darren Magda et al.
SEMINARS IN CANCER BIOLOGY (2006)
Metallocenes as references for the determination of redox potentials by cyclic voltammetry - Permethylated iron and cobalt sandwich complexes, inhibition by polyamine dendrimers, and the role of hydroxy-containing ferrocenes
JR Aranzaes et al.
CANADIAN JOURNAL OF CHEMISTRY (2006)
Cationic, linear Au(I) N-heterocyclic carbene complexes: synthesis, structure and anti-mitochondrial activity
Murray V. Baker et al.
DALTON TRANSACTIONS (2006)
Motexafin gadolinium and zinc induce oxidative stress responses and apoptosis in B-cell lymphoma lines
PS Lecane et al.
CANCER RESEARCH (2005)
Gold and silver complexes with the ferrocenyl-pyrazolate ligand FcCH2pz
EM Barranco et al.
INORGANICA CHIMICA ACTA (2005)
Motexafin gadolinium disrupts zinc metabolism in human cancer cell lines
D Magda et al.
CANCER RESEARCH (2005)
Antitumor antibiotics: Bleomycin, endiynes, and mitomycin
U Galm et al.
CHEMICAL REVIEWS (2005)
Redox-switchable phase tags for recycling of homogeneous catalysts
M Sussner et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
Bleomycins: new methods will allow reinvestigation of old issues
JY Chen et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2004)
Thioredoxin reductase as a potential molecular target for anticancer agents that induce oxidative stress
DDK Smart et al.
CANCER RESEARCH (2004)
Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine
H Maeda et al.
CELL DEATH AND DIFFERENTIATION (2004)
Dinuclear gold(I) complexes of bridging bidentate carbene ligands: synthesis, structure and spectroscopic characterisation
PJ Barnard et al.
DALTON TRANSACTIONS (2004)
Oxygen sensing by HIF hydroxylases
CJ Schofield et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
1,1′-di(arylamino)ferrocenes.: A new family of privileged [N,N] ligands with tunable steric control for applications in homogeneous organometallic catalysis and coordination chemistry
U Siemeling et al.
ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE (2003)
Water stability and cytotoxic activity relationship of a series of ferrocenium derivatives.: ESR insights on the radical production during the degradation process
G Tabbì et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Induction of mitochondrial permeability transition by auranofin, a gold(I)-phosphine derivative
MP Rigobello et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Measuring zinc in living cells. A new generation of sensitive and selective fluorescent probes
KR Gee et al.
CELL CALCIUM (2002)
Redox cycling by motexafin gadolinium enhances cellular response to ionizing radiation by forming reactive oxygen species
D Magda et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
On the mechanism of the antitumor activity of ferrocenium derivatives
D Osella et al.
INORGANICA CHIMICA ACTA (2000)
1,3-di(ferrocenylmethyl)imidazolium and 1-ferrocenylmethyl-3-alkylimidazolium salts: A high yield and facile synthesis
J Howarth et al.
SYNTHETIC COMMUNICATIONS (2000)
分享论文
